A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer

This study is currently recruiting participants.
Verified January 2013 by ICORG- All Ireland Cooperative Oncology Research Group
Sponsor:
Information provided by (Responsible Party):
ICORG- All Ireland Cooperative Oncology Research Group
ClinicalTrials.gov Identifier:
NCT00951535
First received: August 1, 2009
Last updated: January 4, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2026
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)